RCM
ACHV icon

Rotella Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Rotella Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7
Closed -$33K – 404
2015
Q3 		$33K Buy
7
+2
+40% +$12.1K 0.01% 510
2015
Q2 		$27K Buy
+5
New +$24.8K 0.02% 406
2015
Q1 		– Sell
-9
Closed -$45K – 501
2014
Q4 		$45K Buy
+9
New +$44K 0.04% 307

Other funds holding ACHV

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return

Rotella Capital Management's ACHV Position: Q4 2015 in Review

Rotella Capital Management sold out of Achieve Life Sciences (ACHV) in Q4 2015, closing a stake of 7 shares — an estimated $33K sold.

Rotella Capital Management first reported a position in ACHV in Q4 2014 and held it in 3 quarters. The position peaked at $45K in Q4 2014. 47 funds tracked by Wall St. Rank hold ACHV as of Q4 2015.

  • Rotella Capital Management reported no remaining Achieve Life Sciences position as of Q4 2015 after selling out during the quarter.
  • Rotella Capital Management sold 7 Achieve Life Sciences shares in Q4 2015, an estimated $33K.
  • Rotella Capital Management first reported a position in Achieve Life Sciences in Q4 2014 and held it in 3 quarters.
  • Rotella Capital Management's Achieve Life Sciences position peaked at $45K in Q4 2014.
  • 47 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2015.

Based on Rotella Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.